Hectorol doxercalciferol: Phase III data

Pooled 24-week data from 2 double-blind, U.S. Phase III trials in 55 patients showed a 101.4 pg/ml (46%) reduction in PTH levels from baseline in Hectorol arm vs. 4.4 pg/ml (2%) in placebo (p<0.001). ...